Acute phase inflammatory markers in patients with non-steroidal anti-inflammatory drugs (NSAIDs)-induced acute urticaria/angioedema and after aspirin challenge

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 8, 2013, Pages 1048-1052

  Kasperska Zajac A ^a   Grzanka, A ^b   Czecior, E ^b   Misiolek, M ^b   Rogala, B ^a   Machura, E ^c  

^a Allergology and Clinical Immunology   (Poland)

^b Department of Internal Diseases Dermatology and Allergology ^*  (Poland)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; DICLOFENAC; IBUPROFEN; INTERLEUKIN 6; KETOPROFEN;

ACUTE PHASE RESPONSE; ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROVOCATION TEST; SYMPTOM; URTICARIA;

ADOLESCENT; ADULT; ANGIOEDEMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; URTICARIA; YOUNG ADULT;

EID: 84880513022     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2012.04486.x     Document Type: Article

References (18)

1. Szczeklik A, Sanak M,. The broken balance in aspirin hypersensitivity. Eur J Pharmacol 2006; 533: 145-155.
2. Kasperska-Zajac A, Sztylc J, Machura E, Jop G,. Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients. Clin Exp Allergy 2011; 41: 1386-1391.
3. Kasperska-Zajac A,. Acute-phase response in chronic urticaria. J Eur Acad Dermatol Venereol 2011; doi: 10.1111/j.1468-3083.2011.04366.x. [Epub ahead of Print].
4. Gabay C, Kushner I,. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454.
5. Gabay C,. Interleukin-6 and chronic inflammation. Arthritis Res Ther 2006; 8 (Suppl 2): S3.
6. Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64: 1417-1426.
7. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 2007; 62: 1111-1118.
8. Kasperska-Zajac A, Brzoza Z, Rogala B,. Plasma concentration of interleukin 6 (IL-6), and its relationship with circulating concentration of dehydroepiandrosterone sulfate (DHEA-S) in patients with chronic idiopathic urticaria. Cytokine 2007; 39: 142-146.
9. Takahagi S, Mihara S, Iwamoto K, et al. Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria. Allergy 2010; 65: 649-656.
10. Tedeschi A, Asero R, Lorini M, et al. Plasma levels of matrix metalloproteinase-9 in chronic urticaria patients correlate with disease severity and C-reactive protein but not with circulating histamine-releasing factors. Clin Exp Allergy 2010; 40: 875-881.
11. Asero R, Cugno M, Tedeschi A,. Activation of blood coagulation in plasma from chronic urticaria patients with negative autologous plasma skin test. J Eur Acad Dermatol Venereol 2011; 25: 201-205.
12. Fujii K, Konishi K, Kanno Y, Ohgou N,. Acute urticaria with elevated circulating interleukin-6 is resistant to anti-histamine treatment. J Dermatol 2001; 28: 248-250.
13. Kasperska-Zajac A, Jasinska T, Grzanka A, Kowalik-Sztylc A,. Markers of systemic inflammation in delayed pressure urticaria. Int J Dermatol 2011; (in press).
14. Czelej D, Chodorowska G, Lechowska-Mazur I,. Drug-induced urticaria -activity of selected cytokines and acute phase proteins in plasma. Ann Univ Mariae Curie Sklodowska Med 2003; 58: 38-42.
15. Bas M, Hoffmann TK, Bier H, Kojda G,. Increased C-reactive protein in ACE-inhibitor-induced angioedema. Br J Clin Pharmacol 2005; 59: 233-238.
16. Taki M, Watanabe H, Hasegawa T, et al. Angioedema: 6 years experience with 14 cases. Auris Nasus Larynx 2010; 37: 199-204.
17. Vickers MA, Green FR, Terry C, et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 2002; 53: 1029-1034.
18. Pepys MB, Hirschfield GM,. C-reactive protein: a critical update. J Clin Invest 2003; 111: 1805-1812.